Stay updated on BMN 110 Phase 3B in Australian Patients Clinical Trial
Sign up to get notified when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.

Latest updates to the BMN 110 Phase 3B in Australian Patients Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.3.2 replaces v3.2.0. No study content or user-facing features appear to be affected.SummaryDifference0.1%

- Check28 days agoChange DetectedThe notice about government funding lapses and NIH operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check42 days agoChange DetectedNo changes detected to core content on the Study Details page (NCT01966029). Eligibility criteria, study endpoints, and other key information remain the same.SummaryDifference0.4%

- Check71 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference2%

- Check78 days agoChange DetectedUpdated the disorder name capitalization and bumped the revision to v3.1.0 to reflect a version update.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page was updated to Revision v3.0.2, replacing the previous v3.0.1 tag; the 'Back to Top' element was removed.SummaryDifference0.1%

Stay in the know with updates to BMN 110 Phase 3B in Australian Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMN 110 Phase 3B in Australian Patients Clinical Trial page.